AASLD has always put the patient first by providing clinicians with the latest rigorous data on the best treatments for patients with liver diseases, including hepatitis C.
Public policy issues having a direct impact on the discipline are actively monitored and communicated by the Public Policy Committee, which is making recommendations to influence issues as they are raised in the nation's capital.
This year’s Liver Capitol Hill Day will bring together AASLD members and their patients with other organizations interested in Liver Disease. Currently there are 105 people who will meet with their legislators on March 29, 2017.
This year AASLD will lobby on behalf of the following issues: